Retraction notice to "SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma" [iScience 26 (2023) 106994]. [PDF]
Wang S +6 more
europepmc +1 more source
This study developed ECOS‐Net, a transformer‐based multitask framework integrating CT‐derived habitat and 2.5D deep learning features to simultaneously predict early disease control and overall survival in hepatocellular carcinoma patients treated with immune checkpoint inhibitors.
Xiaona Fu +23 more
wiley +1 more source
DCUN1D5 as a New Biomarker and Regulator of Fatty Acid Metabolism in Hepatocellular Carcinoma. [PDF]
Wang T +6 more
europepmc +1 more source
Magnetoreceptor (MagR) regulates iron homeostasis and mitochondrial function in hepatocellular carcinoma (HCC) cells. Specifically, MagR deficiency suppresses tumor cell proliferation, migration, and invasion and enhances sorafenib‐induced ferroptosis through iron accumulation.
Tao Wang +13 more
wiley +1 more source
Extrahepatically growing hepatocellular carcinoma diagnosed after presentation with peritoneal dissemination: a case report. [PDF]
Isomura K +5 more
europepmc +1 more source
Solitary colonic metastasis from hepatocellular carcinoma: A case report and synthesis of 15 published cases. [PDF]
Zhang Z +5 more
europepmc +1 more source
Correction to "Homeobox B13 activates the hypoxia-inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma". [PDF]
europepmc +1 more source
Spontaneous Hepatobiliary Disease in a Breeding Colony of Aotus spp. [PDF]
Hensel ME +4 more
europepmc +1 more source
Vanishing Act: Spontaneous Regression of Hepatocellular Carcinoma After Hepatitis C Virus Treatment and Emergent Transjugular Intrahepatic Portosystemic Shunt Placement. [PDF]
MacDonald J +4 more
europepmc +1 more source

